Citations

Showing 10 of 108094 citations.

Possible mechanisms behind cardiac troponin elevations
Hammarsten, Ola , Mair, Johannes , Möckel, Martin , Jaffe, Allan S. , Mockel, Martin , Lindahl, Bertil , Jaffe, Allan S.

Mayo Clinic

Biomarkers | July 6, 2018 | Volume: 23 | Issue: 8 | Pages: 725-734

10.1080/1354750x.2018.1490969 | PMID 29976112 Get It

Angel Wing Pneumocephalus Sign Following Transsphenoidal Surgery
McLaughlin, Diane , Chaichana, Kaisorn L. , McLaughlin, Diane C, Freeman, William D.

Mayo Clinic

The Neurohospitalist | July 5, 2018 | Volume: 9 | Issue: 2 | Pages: 116-117

10.1177/1941874418786831 | PMID 30915192 Get It

Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Diffuse Large B-Cell Lymphoma: An Individual Patient–Level Analysis of Multiple Randomized Trials (SEAL)
Shi, Qian , Schmitz, Norbert , Dixon, Jesse G. , Pfreundschuh, Michael , Seymour, John F. , Jaeger, Ulrich, Haïoun, Corinne , Tilly, Hervé , Ghesquières, Hervé , Merli, Francesco , Ziepert, Marita , Herbrecht, Raoul , Flament, Jocelyne, Coiffier, Bertrand , Flowers, Christopher R. , Cunningham, David , Fu, Tommy , Shi, Qian , Ou, Fang‐Shu , Habermann, Thomas M. , Dixon, Jesse G

Mayo Clinic

Journal of Clinical Oncology | July 5, 2018 | Volume: 36 | Issue: 25 | Pages: 2593-2602

10.1200/jco.2018.77.9124 | PMID 29975624 Get It

Purpose Overall survival (OS) is the definitive and best-established primary efficacy end point to evaluate diffuse large B-cell lymphoma (DLBCL) therapies, but it requires prolonged follow-up. An earlier end point assessed post-treatment would expedite clinical trial conduct and accelerate patient access to effective new therapies. Our objective was to formally evaluate progression-free survival (PFS) and PFS at 24 months (PFS24) as surrogate end points for OS in first-line DLBCL. Patients and Methods Individual patient data were analyzed from 7,507 patients from 13 multicenter randomized controlled trials of active treatment in previously untreated DLBCL, published after 2002, with sufficient PFS data to predict treatment effects on OS. Trial-level surrogacy examining the correlation of treatment effect estimates of PFS/PFS24 and OS was evaluated using both linear regression ( R2WLS) and Copula bivariable ( R2Copula) models. Prespecified criteria for surrogacy required either R2WLS or R2Copula ≥ 0.80 and neither < 0.7, with lower-bound 95% CI > 0.60. Results Trial-level surrogacy for PFS was strong ( R2WLS = 0.83; R2Copula = 0.85) and met the predefined criteria for surrogacy. At the patient level, PFS strongly correlated with OS. The surrogate threshold effect had a hazard ratio of 0.89. Surrogacy was consistent across comparisons with or without rituximab and with rituximab maintenance trials. Trial-level surrogacy for PFS24 was relatively strong ( R2WLS = 0.77; R2Copula = 0.78) but did not meet prespecified criteria. At the patient level, PFS24 significantly correlated with OS. The surrogate threshold effect had an odds ratio of 1.51. Conclusion This large pooled analysis of individual patient data supports PFS as a surrogate end point for OS in future randomized controlled trials evaluating chemoimmunotherapy in DLBCL. Use of this end point may expedite therapeutic development with the intent of bringing novel therapies to this patient population years before OS results are mature.
Facilitation of Plasminogen Activation by a Plasmin Substrate Containing a Lysyl Residue
Machovich, Raymund, Owen, Whyte G.

Mayo Clinic

Thrombosis and Haemostasis | July 5, 2018 | Volume: 70 | Issue: 05 | Pages: 864-866

10.1055/s-0038-1649684 Get It

SummaryThe plasmin substrate, H-D-norleucyl-hexahydrotyrosyl lysine-p-nitroanilide (Spectrozyme-PL), was found to be equiva lent to 6-aminohexanoate as an enhancer of porcine and human plasminogen activation by urokinase and of removal of the 1-77 peptide of plasminogen by plasmin. Activation of plasminogen lacking kringles 1-4, on the other hand, was not influenced by Spectrozyme PL. Although the rate of activation of human plasminogen and the modification of human plasminogen by plasmin are faster by an order of magnitude than that of the activation and modification of porcine plasminogen, both reactions in the human zymogen, the hydrolysis at arg561-val562 and at lys77lys78, are accelerated by Spectrozyme PL. The findings indicate that kinetic interpretation of plasminogen activation in solutions containing substrates, where the substrate has been incorporated to inhibit feedback proteolysis by plasmin, must account for the cofactor activity as well as the inhibitory activity of the substrate.
Unrecognized pre‐transplant disseminated Coxiella burnetti infection diagnosed in a post‐transplant heart‐kidney recipient
Jandhyala, Deeksha , Farid, Saira, Mahmood, Maryam , Deziel, Paul J. , Saleh, Omar Abu , Raoult, Didier , Deziel, Paul, Abu Saleh, Omar , Mahmood, Maryam , Beam, Elena

Mayo Clinic

Transplant Infectious Disease | July 5, 2018 | Volume: 20 | Issue: 5 | Pages: No page available

10.1111/tid.12962 | PMID 29975810 Get It

AbstractTo the best of our knowledge, we report the first case of pre‐transplant unrecognized disseminated Coxiella burnetii infection, unmasked in the post‐transplant period leading to both heart and kidney allograft dysfunction. A 59 year old man with a history of simultaneous heart‐kidney transplantation due to end stage heart failure from severe aortic regurgitation (AR) and cryoglobulinemic immune complex mediated concentric necrotizing glomerulonephritis (GN), presents with a history of intermittent fevers and fatigue. Prior to transplantation he was treated for multiple episodes of culture negative endocarditis requiring bio‐prosthetic valve replacement. Evaluation of fever included a transesophageal echocardiogram (TEE) that revealed a large hyperechoic mass on the anterior mitral leaflet with perforation, severe mitral regurgitation and moderate AR. Blood cultures were negative at that time. Owing to development of allograft mitral and aortic valve insufficiency, he underwent allograft bio‐prosthetic mitral valve (MV) replacement and aortic valvuloplasty 2 years following his transplantation. Pathologic examination of the allograft mitral valve demonstrated fibrinopurulent exudate with degenerating bacterial organisms, consistent with vegetation and myxoid degenerative changes. Due to a high suspicion for native heart C. burnetii prosthetic valve endocarditis prior to transplantation, we re‐evaluated the native explanted heart histopathology, as well as the explanted allograft MV. Cardiac allograft and native MV were positive for C. burnetii by real‐time PCR. C. burnetii serology was consistent with persistent infection as well.
Evolving Technologies for the Treatment of Type B Aortic Dissections—A Case Report and Review of the Literature
Helder, Meghana R.K. , Bacharach, J. Michael

Mayo Clinic

Journal of the Minneapolis Heart Institute Foundation | July 5, 2018 | Volume: 2 | Issue: 1 | Pages: 38-43

10.21925/mplsheartjournal-d-17-00003 Get It

Linking Education to Action: A Program to Increase Research Participation Among African American Women
Breitkopf, Carmen Radecki , Williams, Karen Patricia , Ridgeway, Jennifer L. , Parker, Monica W. , Strong-Simmons, Alice, Halyard, Michele Y. , Ridgeway, Jennifer L , Hayes, Sharonne N.

Mayo Clinic

Journal of Women's Health | July 5, 2018 | Volume: 27 | Issue: 10 | Pages: 1242-1249

10.1089/jwh.2017.6791 | PMID 29975586 Get It

Background: Underrepresentation of African American women as research participants contributes to health disparities. Contemporary studies have focused on clinical trial (CT) participation; epidemiologic and genetic studies utilizing medical records and/or biological samples have received less attention. In partnership with The Links, Incorporated (The Links), a national service organization of professional African American women, this study sought to examine attitudes regarding chart review (CR) studies, genetic studies/biobanking (GEN), and CTs; develop; and evaluate an online education-to-action program. Methods: In phase 1, focus groups were convened with members of The Links to inform the content and format of the program. Phases 2 and 3 involved designing and evaluating the program, respectively. Results: Thirty-four women across three focus groups shared attitudes and perceptions regarding research and provided guidance for program development. Subsequently, 244 women completed the program (77% response rate), including pre- and post-assessments. Participants indicating that they “definitely” or “probably” (responses combined) intend to participate in research increased from 36.5% to 69.3% (pre/post-program). Agreement with the statement “research in the U.S. is ethical” increased (52.9% to 74.4%) as did factual knowledge regarding each of the study types. There was a decrease in reporting “little or no understanding” of study types (Pre/Post: GEN: 66%/24.9%, CR: 62.9%/18.4%, CTs: 40.7%/15.5%). Pre-program, few were “very positive” about the study types (14.3% GEN, 15.0% CR, 28.6% CTs); post-program ratings increased and equalized (42.8% GEN, 43.0% CR, 42.5% CTs). Conclusions: An online education-to-action program targeting professional African American women improved knowledge, perceptions of ethics, and intent to participate in biomedical research.
Up-front rituximab maintenance improves outcome in patients with follicular lymphoma: a collaborative Nordic study
Clausen, Michael Roost , Plesner, Torben , Pasanen, Annika , Kuismanen, T., Bentzen, Hans, Jørgensen, Judit , Sillesen, Ida Blok, Himmelstrup, Bodil , Rønnov‐Jessen, Dorthe, Jensen, Kiersten, Pettinger, Adam, Ludvigsen, Maja , Leppä, Sirpa , d’Amore, Francesco, Joergensen, Judit Mészáros , Madsen, Charlotte Bernhard , Clausen, Michael Roost

Mayo Clinic

Blood Advances | July 5, 2018 | Volume: 2 | Issue: 13 | Pages: 1562-1571

10.1182/bloodadvances.2018017673 | PMID 29976619 Get It

Key PointsPatients who received R-chemo followed by MR had an improved 5-year PFS and OS independent of prognostic factors. A reduction of the risk of HT was observed among the MR patients of the training, but not of the validation, cohort.
Folic acid supplementation improves vascular endothelial function, yet not skin blood flow during exercise in the heat, in patients with heart failure
Balmain, Bryce N. , Jay, Ollie , Morris, Norman , Stewart, Glenn M. , Shiino, Kenji, McFarland, Amelia J. , Jayasinghe, Rohan, Chan, Jonathan , Sabapathy, Surendran

Mayo Clinic

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology | July 5, 2018 | Volume: 315 | Issue: 4 | Pages: R810-R819

10.1152/ajpregu.00132.2018 | PMID 29975566 Get It

Heart failure (HF) patients are susceptible to heat strain during exercise, secondary to blunted skin blood flow (SkBF) responses, which may be explained by impaired nitric oxide (NO)-dependent vasodilation. Folic acid improves vascular endothelial function and SkBF through NO-dependent mechanisms in healthy older individuals and patients with cardiovascular disease. We examined the effect of folic acid supplementation (5 mg/day for 6 wk) on vascular function [brachial artery flow-mediated dilation (FMD)] and SkBF responses [cutaneous vascular conductance (CVC)] during 60 min of exercise at a fixed metabolic heat production (300 ẆHprod) in a 30°C environment in 10 patients with HF (New York Heart Association Class I–II) and 10 healthy controls (CON). Serum folic acid concentration increased in HF [preintervention (pre): 1.4 ± 0.2; postintervention (post): 8.9 ± 6.7 ng/ml, P = 0.01] and CON (pre: 1.3 ± 0.6; post: 5.2 ± 4.9 ng/ml, P = 0.03). FMD improved by 2.1 ± 1.3% in HF ( P < 0.01), but no change was observed in CON postintervention ( P = 0.20). During exercise, the external workload performed on the cycle ergometer to attain the fixed level of heat production for exercise was similar between groups (HF: 60 ± 13; CON: 65 ± 20 external workload, P = 0.52). Increases in CVC during exercise were similar in HF (pre: 0.89 ± 0.43; post: 0.83 ± 0.45 au/mmHg, P = 0.80) and CON (pre: 2.01 ± 0.79; post: 2.03 ± 0.72 au/mmHg, P = 0.73), although the values were consistently lower in HF for both pre- and postintervention measurement intervals ( P < 0.05). These findings demonstrate that folic acid improves vascular endothelial function in patients with HF but does not enhance SkBF during exercise at a fixed metabolic heat production in a warm environment.
Neuroendocrine Tumor Diagnosis and Management: 68Ga-DOTATATE PET/CT
Garg, Ishan , Kandathil, Asha , Kendi, Tuba, Zanetti, Maria J. Baladron, Kuyumcu, Serkan , Subramaniam, Rathan M. , Şanlı, Yasemin

Mayo Clinic

American Journal of Roentgenology | July 5, 2018 | Volume: 211 | Issue: 2 | Pages: 267-277

10.2214/ajr.18.19881 | PMID 29975116 Get It